BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9275350)

  • 1. P53 gene abnormalities in osteosarcoma.
    Guo W; Wang X; Feng C
    Chin Med J (Engl); 1996 Oct; 109(10):752-5. PubMed ID: 9275350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [p53 antioncogene abnormal in osteosarcoma].
    Guo W; Wang SW; Feng CH
    Zhonghua Wai Ke Za Zhi; 1994 Jul; 32(7):412-5. PubMed ID: 7842979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of the RB1 gene and the p53 gene in human osteosarcomas.
    Scholz RB; Kabisch H; Weber B; Röser K; Delling G; Winkler K
    Pediatr Hematol Oncol; 1992; 9(2):125-37. PubMed ID: 1524989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation spectrum of p53 gene in highly malignant human osteosarcomas.
    Radig K; Schneider-Stock R; Oda Y; Neumann W; Mittler U; Roessner A
    Gen Diagn Pathol; 1996 Jun; 142(1):25-32. PubMed ID: 8793483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation spectrum of the p53 gene in bone and soft tissue sarcomas.
    Toguchida J; Yamaguchi T; Ritchie B; Beauchamp RL; Dayton SH; Herrera GE; Yamamuro T; Kotoura Y; Sasaki MS; Little JB
    Cancer Res; 1992 Nov; 52(22):6194-9. PubMed ID: 1423262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency and structure of p53 rearrangements in human osteosarcoma.
    Miller CW; Aslo A; Tsay C; Slamon D; Ishizaki K; Toguchida J; Yamamuro T; Lampkin B; Koeffler HP
    Cancer Res; 1990 Dec; 50(24):7950-4. PubMed ID: 2253237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 gene gets altered by various mechanisms: studies in childhood sarcomas and retinoblastoma.
    Ghule P; Kadam PA; Jambhekar N; Bamne M; Pai S; Nair C; Banavali S; Puri A; Agarwal M
    Med Sci Monit; 2006 Dec; 12(12):BR385-396. PubMed ID: 17136003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of SV40 in human osteosarcoma DNA.
    Mendoza SM; Konishi T; Miller CW
    Oncogene; 1998 Nov; 17(19):2457-62. PubMed ID: 9824156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular analysis of tumor suppressor genes p16INK4 and TP53 of osteosarcomas in Spanish children].
    Patiño García A; Sierrasesúmaga Ariznabarreta L
    An Esp Pediatr; 1997 Nov; 47(5):478-82. PubMed ID: 9586287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
    Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ErbB-2 expression is correlated with poor prognosis for patients with osteosarcoma.
    Onda M; Matsuda S; Higaki S; Iijima T; Fukushima J; Yokokura A; Kojima T; Horiuchi H; Kurokawa T; Yamamoto T
    Cancer; 1996 Jan; 77(1):71-8. PubMed ID: 8630943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 mutation is infrequent in clear cell carcinoma of the ovary.
    Ho ES; Lai CR; Hsieh YT; Chen JT; Lin AJ; Hung MH; Liu FS
    Gynecol Oncol; 2001 Feb; 80(2):189-93. PubMed ID: 11161858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of retinoblastoma susceptible gene accompanied by c-myc amplification in human bone and soft tissue tumors.
    Ozaki T; Ikeda S; Kawai A; Inoue H; Oda T
    Cell Mol Biol (Noisy-le-grand); 1993 Mar; 39(2):235-42. PubMed ID: 8513277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COPS3 amplification and clinical outcome in osteosarcoma.
    Yan T; Wunder JS; Gokgoz N; Gill M; Eskandarian S; Parkes RK; Bull SB; Bell RS; Andrulis IL
    Cancer; 2007 May; 109(9):1870-6. PubMed ID: 17366602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitization and caffeine potentiation of cisplatin cytotoxicity resulting from introduction of wild-type p53 gene in human osteosarcoma.
    Tsuchiya H; Mori Y; Ueda Y; Okada G; Tomita K
    Anticancer Res; 2000; 20(1A):235-42. PubMed ID: 10769661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional elucidation of MiR-34 in osteosarcoma cells and primary tumor samples.
    He C; Xiong J; Xu X; Lu W; Liu L; Xiao D; Wang D
    Biochem Biophys Res Commun; 2009 Oct; 388(1):35-40. PubMed ID: 19632201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deregulated p21(WAF1) overexpression impacts survival of surgically resected esophageal squamous cell carcinoma patients.
    Goan YG; Hsu HK; Chang HC; Chou YP; Chiang KH; Cheng JT
    Ann Thorac Surg; 2005 Sep; 80(3):1007-16. PubMed ID: 16122475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of the WWOX gene and frequent loss of its protein expression in human osteosarcoma.
    Yang J; Cogdell D; Yang D; Hu L; Li H; Zheng H; Du X; Pang Y; Trent J; Chen K; Zhang W
    Cancer Lett; 2010 May; 291(1):31-8. PubMed ID: 19896763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of the p53 protein in human osteosarcoma].
    Nishikawa T; Yamamoto T; Mizuno K; Fujimori T; Maeda S; Ugai K
    Nihon Seikeigeka Gakkai Zasshi; 1994 May; 68(5):400-6. PubMed ID: 8051467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular genetic considerations in osteosarcoma.
    Hansen MF
    Clin Orthop Relat Res; 1991 Sep; (270):237-46. PubMed ID: 1679382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.